Botanix Pharmaceuticals Limited
BXPHF
$0.02
$0.008.07%
OTC PK
Corporate Info
Website
Phone Number
61 8 6555 2945
Address
Tower 5, Collins Square
Level 23
727 Collins Street
Melbourne, WA 3008
Level 23
727 Collins Street
Melbourne, WA 3008
Country
Australia
Year Founded
1984
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
Business Description
Botanix Pharmaceuticals Limited operates as a commercial dermatology company in Australia and the United States. The company’s lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age and older. Its product pipeline includes BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1801 for treating staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 for the treatment of papulopustular rosacea; and BTX 1204A for treating atopic dermatitis. The company was incorporated in 1984 and is based in Melbourne, Australia.